TNF and diabetic retinopathy: A soluble TNF-α receptor-Fc hybrid, such as etanercept [115], is able to normalize vascular permeability and leukostasis; this suggests that TNF-α contributes to diabetic retinopathy, perhaps by preventing endothelial-cell damage from adhering leukocytes [86].